Fennec Pharmaceuticals Inc (FENC)
SG&A Expense Growth
4.72%
Quarterly · Period ending:
FENC SG&A Expense Growth
Latest reported4.72%period ending
Latest reported4.72%period ending
FENC Quarterly SG&A Growth (QoQ) (0.00% → 4.72%)
Latest values, visible window
High-resolution chart · PNG
FENC sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 4.7234% | |
| 0.4193% | |
| 21.6101% | |
| 5.7648% | |
| 24.3951% | |
| 11.6953% | |
| -24.0813% | |
| -7.0562% | |
| 4.1061% | |
| 2.261% | |
| 50.7303% | |
| -8.2451% | |
| 14.413% | |
| -8.2898% | |
| 5.8698% | |
| 81.8721% | |
| 83.8786% | |
| -42.7524% | |
| 25.6909% | |
| -6.0577% | |
| 24.4515% | |
| 9.3328% | |
| -48.9423% | |
| 20.5961% | |
| 52.498% | |
| -1.5719% | |
| 132.3034% | |
| -62.4473% | |
| 181.8632% | |
| -26.9899% | |
| 31.619% | |
| -43.76% | |
| 69.4192% | |
| -32.3511% | |
| -3.8371% | |
| 47.8185% | |
| 109.8901% | |
| -43.8272% | |
| 115.0442% | |
| -20.4225% | |
| 39.5577% | |
| -15.2083% | |
| 92% | |
| -49.4949% | |
| 21.0269% | |
| -34.6645% | |
| 17.8908% | |
| -38.1119% | |
| 69.901% | |
| 54.908% | |
| 18.5455% | |
| -26.2735% | |
| 3.8997% | |
| -36.121% | |
| 105.8608% | |
| -30% | |
| 21.875% | |
| -19.1919% | |
| -21.5842% | |
| 49.4083% | |
| -52.1246% | |
| 33.9658% | |
| -34.6964% | |
| -65.7906% | |
| 1,062.069% | |
| 427.4194% | |
| -121.1604% | |
| -5.7878% | |
| -53.789% | |
| -35.4127% | |
| 117.9916% | |
| -49.0948% | |
| -11.4986% | |
| 89.1266% | |
| -41.9255% | |
| 21.8159% | |
| -17.2234% | |
| 27.2222% | |
| 11.889% | |
| -5.3446% | |
| -4.8193% | |
| 26.3675% | |
| -39.2432% | |
| 8.1016% | |
| 25.3538% | |
| -80.1714% | |
| 188.9814% | |
| -12.9266% | |
| 54.9627% | |
| 36.7167% | |
| 52.4006% | |
| -27.9495% | |
| -9.6547% | |
| 171.2457% | |
| 31.5371% | |
| -26.5689% | |
| 28.9112% | |
| 1.9241% | |
| -18.3383% | |
| 0% |